SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_
Date of Report (date of earliest event reported)
(Exact Name of Registrant as Specified in its Charter)
of Incorporation) File Number) Identification Number)
(Address of Principal Executive Offices
Including Zip Code)
(Registrant’s Telephone Number,
Including Area Code
______________
(Former Name or Former Address if Changed
Since Last Report)
Page 1 of 3 pages
Item 7.01 Regulation FD Disclosure
On February 6, 2023, Biomerica, Inc. (“the “Company”) presented an investor presentation to the investment community. The investor presentation is attached hereto as Exhibit 99.1.
The investor presentation is being furnished pursuant to General Instruction B.2 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor is it subject to the liabilities of that section or deemed incorporated by reference in any filing by the Company under the Exchange Act unless specifically identified therein as being incorporated therein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit
Number Description
99.1 Investor Presentation
Page 2 of 3 pages
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: February 7, 2023 Biomerica, Inc.
By: /s/ Zackary S. Irani
Zackary S. Irani
Chief Executive Officer
Page 3 of 3 pages